KPC logo

KPC

Asia, Yunnan, China, Kunming

Description

KPC is a pharmaceutical company that develops and manufactures natural botanical drugs.

Investor Profile

KPC has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does KPC frequently co-invest with?

VentureHealth
North America, California, United States, San Jose
Co-Investments: 1
AstraZeneca
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
GF Venture Capital
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Buttonwood Group Advisors
North America, New York, United States, New York
Co-Investments: 1
Virtus Inspire Ventures
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
InCube Ventures
North America, California, United States, San Jose
Co-Investments: 1
Ping An Ventures
Asia, Shandong, China, Pudong
Co-Investments: 1

What are some of recent deals done by KPC?

Rani Therapeutics

San Jose, California, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownFeb 27, 2016